tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EVE Health Group Reports Financial Downturn for FY 2025

Story Highlights
EVE Health Group Reports Financial Downturn for FY 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

EVE Health Group Limited ( (AU:EVE) ) just unveiled an announcement.

EVE Health Group reported a 19% decrease in revenue from ordinary activities for the financial year ending June 30, 2025, compared to the previous year. The company also saw a 17% reduction in net loss attributable to members, with no dividends declared during the period. Despite the financial downturn, EVE Health Group continues to focus on its core operations in the health sector, aiming to strengthen its market position through its subsidiaries.

More about EVE Health Group Limited

EVE Health Group (ASX: EVE) is an Australian-based health company focused on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries Meluka Australia and Nextract, EVE delivers science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.

Average Trading Volume: 486,375

Technical Sentiment Signal: Sell

Current Market Cap: A$7.88M

See more insights into EVE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1